Back to Search
Start Over
Correction: Combined Inhibition of NEDD8-activating Enzyme and mTOR Suppresses NF2 Loss–driven Tumorigenesis
- Source :
- Molecular Cancer Therapeutics. 20:450-450
- Publication Year :
- 2021
- Publisher :
- American Association for Cancer Research (AACR), 2021.
-
Abstract
- In the original version of [this article][1] ([1][2]), the CYR61 Western blot on the left-hand side of Fig. 2C was accidentally duplicated to the right-hand portion of the figure panel. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this
- Subjects :
- 0301 basic medicine
Cancer Research
medicine.diagnostic_test
business.industry
Regret
Biology
medicine.disease_cause
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Text mining
Oncology
Western blot
030220 oncology & carcinogenesis
CYR61
NEDD8 Activating Enzyme
medicine
Cancer research
business
Carcinogenesis
PI3K/AKT/mTOR pathway
Subjects
Details
- ISSN :
- 15388514 and 15357163
- Volume :
- 20
- Database :
- OpenAIRE
- Journal :
- Molecular Cancer Therapeutics
- Accession number :
- edsair.doi...........66a09092621443f583e2383fad3490aa